Anti-Human GRO-α/MGSA (CXCL1) 0 ReviewsSubmit a Review Product Details Catalogue Number: 500-P92 Description: Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human GRO-alpha/MGSA (CXCL1). Anti-Human GRO-alpha/MGSA (CXCL1)-specific antibody was purified by affinity chromatography employing immobilized Human GRO-alpha/MGSA (CXCL1) matrix. Immunogen: E.coli derived Recombinant Human GRO-α/MGSA (CXCL1) (PeproTech catalog# 300-11) Sandwich ELISA: To detect Human GRO-α/MGSA by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human GRO-α/MGSA (500-P92Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human GRO-α/MGSA. Western Blot: To detect Human GRO-α/MGSA by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human GRO-α/MGSA is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Human References SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Angiogenesis/Cardiovascular Chemotaxis Inflammation Neurobiology Wound Healing product.subtitle.recentcitations First Author Bouhaddou, M Title The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Citation Cell; 182(3) pg685-712.e19 PubMed Id 32645325 First Author Cheng, W Title Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression. Citation PLoS ONE; 7(3) pge34352 PubMed Id 22479608 First Author Hol, J Title Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies. Citation PLoS ONE; 7(7) pge40673 PubMed Id 22815786
